Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive rats

Clin Sci (Lond). 1981 Dec:61 Suppl 7:343s-345s. doi: 10.1042/cs061343s.

Abstract

1. Immunoreactive beta-endorphin (IR-beta EP) was two- to three-fold higher in pituitary neuro-intermediate lobes (N-IL) of spontaneously hypertensive rats (SHR) than of normotensive Wistar--Kyoto (NT-WKY) controls. 2. Plasma levels of IR-beta EP were lower in SHR than in NT-WKY rats. 3. Intravenous injections of morphine lowered blood pressure of both SHR and NT-WKY rats to the same level; naloxone restored blood pressure of both groups to pre-morphine values. 4. Infusion of bromocriptine in SHR for 1 week lowered blood pressure and N-IL IR-beta EP concentration. 5. These results confirm and extend postulated dopaminergic defect in this model of hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Bromocriptine / therapeutic use*
  • Endorphins / blood*
  • Female
  • Hypertension / blood
  • Hypertension / drug therapy*
  • Rats
  • Rats, Inbred Strains
  • beta-Endorphin

Substances

  • Endorphins
  • Bromocriptine
  • beta-Endorphin